Highly Selective CB1 Cannabinoid Receptor Ligands and Novel CB1/VR1 Vanilloid Receptor “Hybrid” Ligands
Authors:
- V. Di MarzoV. Di Marzo
- T. BisognoTBT. Bisogno
- L. De PetrocellisLPL. De Petrocellis
- I. BrandiIBI. Brandi
- R.G. JeffersonRJR.G. Jefferson
- R.L. WincklerRWR.L. Winckler
- J.B. DavisJDJ.B. Davis
- O. DasseODO. Dasse
- A. MahadevanAMA. Mahadevan
- R.K. RazdanRRR.K. Razdan
- B.R. MartinBMB.R. Martin
- 1 February 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 281 (2) , 444-451
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout MiceJournal of Neurochemistry, 2000
- Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and humanProceedings of the National Academy of Sciences, 2000
- The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)British Journal of Pharmacology, 2000
- Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptorsProceedings of the National Academy of Sciences, 1999
- Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamideNature, 1999
- Anandamide and WIN 55212‐2 inhibit cyclic AMP formation through G‐protein‐coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytesEuropean Journal of Neuroscience, 1999
- EndocannabinoidsEuropean Journal of Pharmacology, 1998
- The capsaicin receptor: a heat-activated ion channel in the pain pathwayNature, 1997
- Pharmacology of cannabinoid CB1 and CB2 receptorsPharmacology & Therapeutics, 1997
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992